Psychemedics Return on Tangible Equity 2010-2023 | PMD
Current and historical return on tangible equity values for Psychemedics (PMD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Psychemedics Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2023-12-31 |
$-0.00B |
$0.01B |
-48.48% |
| 2023-09-30 |
$-0.00B |
$0.01B |
-43.24% |
| 2023-06-30 |
$-0.00B |
$0.01B |
-19.05% |
| 2023-03-31 |
$-0.00B |
$0.01B |
-8.89% |
| 2022-12-31 |
$-0.00B |
$0.01B |
-8.51% |
| 2022-09-30 |
$-0.00B |
$0.01B |
-16.67% |
| 2022-06-30 |
$-0.00B |
$0.01B |
-8.00% |
| 2022-03-31 |
$-0.00B |
$0.01B |
-7.84% |
| 2021-12-31 |
$-0.00B |
$0.01B |
-7.69% |
| 2021-09-30 |
$0.00B |
$0.01B |
0.00% |
| 2021-06-30 |
$-0.00B |
$0.01B |
-15.38% |
| 2021-03-31 |
$-0.00B |
$0.01B |
-30.19% |
| 2020-12-31 |
$-0.00B |
$0.01B |
-28.57% |
| 2020-09-30 |
$-0.00B |
$0.01B |
-26.67% |
| 2020-06-30 |
$-0.00B |
$0.01B |
-12.31% |
| 2020-03-31 |
$0.00B |
$0.02B |
5.80% |
| 2019-12-31 |
$0.00B |
$0.02B |
11.27% |
| 2019-09-30 |
$0.00B |
$0.02B |
21.92% |
| 2019-06-30 |
$0.00B |
$0.02B |
21.62% |
| 2019-03-31 |
$0.00B |
$0.02B |
21.62% |
| 2018-12-31 |
$0.00B |
$0.02B |
21.33% |
| 2018-09-30 |
$0.01B |
$0.02B |
26.67% |
| 2018-06-30 |
$0.01B |
$0.02B |
27.40% |
| 2018-03-31 |
$0.01B |
$0.02B |
28.17% |
| 2017-12-31 |
$0.01B |
$0.02B |
35.29% |
| 2017-09-30 |
$0.01B |
$0.02B |
36.92% |
| 2017-06-30 |
$0.01B |
$0.02B |
51.61% |
| 2017-03-31 |
$0.01B |
$0.02B |
62.07% |
| 2016-12-31 |
$0.01B |
$0.02B |
52.83% |
| 2016-09-30 |
$0.01B |
$0.01B |
40.82% |
| 2016-06-30 |
$0.00B |
$0.01B |
25.53% |
| 2016-03-31 |
$0.00B |
$0.01B |
8.51% |
| 2015-12-31 |
$0.00B |
$0.01B |
8.33% |
| 2015-09-30 |
$0.00B |
$0.01B |
16.33% |
| 2015-06-30 |
$0.00B |
$0.01B |
16.00% |
| 2015-03-31 |
$0.00B |
$0.01B |
23.53% |
| 2014-12-31 |
$0.00B |
$0.01B |
31.37% |
| 2014-09-30 |
$0.00B |
$0.01B |
32.00% |
| 2014-06-30 |
$0.00B |
$0.01B |
32.65% |
| 2014-03-31 |
$0.00B |
$0.01B |
33.33% |
| 2013-12-31 |
$0.00B |
$0.01B |
34.04% |
| 2013-09-30 |
$0.00B |
$0.01B |
26.09% |
| 2013-06-30 |
$0.00B |
$0.01B |
26.09% |
| 2013-03-31 |
$0.00B |
$0.01B |
26.67% |
| 2012-12-31 |
$0.00B |
$0.01B |
26.67% |
| 2012-09-30 |
$0.00B |
$0.01B |
26.67% |
| 2012-06-30 |
$0.00B |
$0.01B |
27.27% |
| 2012-03-31 |
$0.00B |
$0.01B |
27.27% |
| 2011-12-31 |
$0.00B |
$0.01B |
27.91% |
| 2011-09-30 |
$0.00B |
$0.01B |
28.57% |
| 2011-06-30 |
$0.00B |
$0.01B |
29.27% |
| 2011-03-31 |
$0.00B |
$0.01B |
30.00% |
| 2010-12-31 |
$0.00B |
$0.01B |
30.77% |
| 2010-09-30 |
$0.00B |
$0.01B |
42.11% |
| 2010-06-30 |
$0.00B |
$0.01B |
43.24% |
| 2010-03-31 |
$0.00B |
$0.01B |
33.33% |
| 2009-12-31 |
$0.00B |
$0.01B |
21.62% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.015B |
$0.022B |
|
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|
